Is compulsory licensing the answer to the US’ buying of all Remdesivir?
Tuesday this week, it was revealed that Gilead, the producer of Remdesivir, which is currently known as the best drug against COVID-19, had sold nearly almost all of the next three months’ production of its medication to the US health department, leaving the rest of the world without access to buy … Continue reading Is compulsory licensing the answer to the US’ buying of all Remdesivir?
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed